Title:
Development of Novel Imaging Technologies (Phased Innovation Award)

Contact:

Houston Baker, Ph.D.
Diagnostic Imaging Program
Telephone: 301-496-9531 (direct) or 301 594 9117 (office)
E-mail: bakerhou@mail.nih.gov

Objective of Project:

The purpose of this reissued initiative is to solicit R21/R33 phased innovation applications from investigators who propose to develop new or enhanced in vivo imaging technologies and methods for feasibility studies, prototype development, and limited pilot or clinical studies. NIBIB is expected to join in this reissued initiative.

Description of Project:

This phased innovation initiative will facilitate development of novel imaging technologies for early detection, screening, diagnosis, and image-guided treatment of cancer and other diseases. It will stimulate (a) development of innovative image acquisition, enhancement, and analysis methods, including high risk/high gain research on technologies that exploit our knowledge of the molecular basis of cancer or other disease, and (b) the integration of these emerging technologies with traditional imaging methods for more effective solutions for health care delivery. This reissued Program Announcement will continue prior R33 support for a limited number of copies of system prototypes for pilot or feasibility evaluations using either pre-clinical models or clinical studies. Investigators with innovative ideas for technology and methods development in diagnostic imaging have previously had difficulty identifying potential funding sources. As a consequence of that situation, this initiative has become an important source of funding for developers of novel imaging technologies, and its importance is expected to grow as more of them, through this announcement, learn about this initiative. This initiative provides investigators at all career levels with access to a defined level of funding that should be adequate for the initial feasibility testing of high-risk/high-impact concepts, and for viable concepts, building prototypes, and collecting preliminary data. Applications from academia, industry, and independent research organizations are encouraged.